← MeridianDesk

MeridianDesk: Terms of Use

Last updated: July 15, 2026

These terms govern your use of MeridianDesk. Please read them before you use the app.

1. Purpose, scope, and definitions. These Terms of Use (the "Terms") govern the use of the MeridianDesk application (the "Application"), macOS software published by Aubora SAS (société en formation), Paris, France ("Aubora"). In these Terms, "prescriber" or "user" means the qualified health professional who installs and uses the Application; "patient data" means the data that a patient has exported from the Meridian application and that the user imports into the Application. By installing or using the Application, the user accepts these Terms.

2. Nature of the software. The Application reads imported patient data and recomputes an estimated pharmacokinetic curve, expressed in milligrams of d-equivalent per stimulant class, using a one-compartment (Bateman) model built on population-average parameters. The Application is a display and calculation aid for professional review. It is not a medical device; it performs no measurement; and it is not intended to diagnose, treat, cure, prevent, or monitor any disease or condition. It provides no dosing, timing, diagnostic, or treatment recommendation.

3. No medical advice and clinical responsibility. The Application does not provide medical advice. All values and curves shown are estimates for the user to evaluate. The independent professional judgment of the user governs every clinical interpretation and decision. The user retains sole responsibility for any clinical decision and for the care of the patient, and must rely on the full clinical picture rather than on any element displayed by the Application. Where a substance cannot be matched to a specific catalogue entry, a generic fallback profile is applied and the corresponding result is a broad approximation only.

4. Intended users. The Application is intended solely for licensed prescribers and other qualified health professionals acting within their competence. It is not intended for patients or for the general public, and it is not intended to be relied upon by anyone lacking the professional qualification required to interpret the information displayed.

5. Licence. Subject to these Terms, Aubora grants the user a personal, non-exclusive, non-transferable, and revocable licence to install and use the Application for the user's own professional purposes. No right is granted other than as expressly set out in these Terms.

6. Restrictions. The user shall not, and shall not permit any third party to: copy, reproduce, distribute, redistribute, publish, rent, lend, sell, sublicense, or otherwise make the Application available to any third party; reverse engineer, decompile, disassemble, or otherwise attempt to derive the source code, structure, or underlying ideas of the Application; modify, adapt, translate, or create derivative works of the Application; extract, copy, or reuse the pharmacokinetic model or the medication catalogue, in whole or in part; or remove or alter any proprietary notice. These restrictions apply except to the extent that such acts cannot lawfully be prohibited under mandatory applicable law.

7. Intellectual property. The Application, its pharmacokinetic model, its medication catalogue, and all related content, structure, and materials are and remain the exclusive property of Aubora SAS and are protected by intellectual property law. These Terms transfer no ownership of any kind to the user.

8. Local-only and read-only operation. The Application operates locally on the user's Mac. Patient data, imported files, and computed results remain on that Mac and are not transmitted to Aubora or to any third party. The Application is read-only with respect to the patient's own data and cannot modify, add to, or delete data on the patient's device. The handling of data is described further in the Privacy Notice.

9. Data protection and professional secrecy. The user is the data controller for the patient data imported into the Application and is solely responsible for handling it lawfully, including under the General Data Protection Regulation (GDPR), under applicable professional secrecy obligations (in France, the secret médical), and, in France, under the Code de la santé publique. Patient health data is a special category of personal data under Article 9 of the GDPR. The user is responsible for securing the device, for honoring patients' rights, and for any retention or deletion of the data, which Aubora cannot perform because it holds no such data.

10. Acceptable use. The user shall use the Application only for lawful professional purposes and in accordance with these Terms, the applicable rules of the user's profession, and applicable law. The user shall not use the Application in any manner that could compromise the confidentiality or the security of patient data.

11. No warranty. The Application is provided "as is" and "as available", without warranty of any kind, whether express or implied, including any implied warranty of merchantability, fitness for a particular purpose, accuracy, or non-infringement, to the fullest extent permitted by law. Aubora does not warrant that the Application will be error-free or uninterrupted, or that any estimate it produces will correspond to a patient's actual physiology.

12. Limitation of liability. To the fullest extent permitted by law, Aubora shall not be liable for any indirect or consequential loss, nor for any clinical decision, diagnosis, treatment, or outcome arising from the use of, or reliance on, the Application or any estimate it displays. Nothing in these Terms excludes or limits any liability that cannot lawfully be excluded or limited.

13. Indemnity. The user shall hold Aubora harmless from any third-party claim arising from the user's breach of these Terms or from the user's unlawful handling of patient data, to the extent permitted by law and except where such claim results from Aubora's own fault.

14. Changes to the Application and to these Terms. Aubora may update, modify, or discontinue the Application or any of its features, and may amend these Terms, in particular to reflect changes in the Application or in applicable law. Continued use of the Application after an updated version of the Terms is made available constitutes acceptance of the updated Terms.

15. Term and termination. These Terms apply for as long as the user uses the Application. The licence terminates automatically if the user breaches these Terms. The user may end the licence at any time by ceasing to use and by uninstalling the Application. The provisions that by their nature should survive termination, including those on intellectual property, warranties, and liability, continue to apply.

16. Governing law, jurisdiction, acceptance, and contact. These Terms are governed by French law. Any dispute relating to the Application or to these Terms shall be submitted to the competent courts of Paris, France, without prejudice to any mandatory protection from which the user may benefit under the rules of their place of establishment. Use of the Application requires prior acceptance of these Terms. Questions concerning these Terms may be addressed to Aubora SAS at contact@aubora.co.